The report “Europe Topical Drug Delivery Market is expected to reach USD 60.3 billion by
2024 from USD 31.3 billion in 2016, growing at a CAGR of 8.5% in the forecast
period 2017 to 2024”, also the Europe Topical Drug Delivery Market, By
Product Type {Topical (Solid, Liquid, Semi-Solid), Transdermal (Patches,
Gels)}, End-User (Hospitals, Clinics, Home Healthcare, Diagnostic Centers),
Distribution Channel (Direct Tenders, Retail), Country (Germany, France, U.K.,
Belgium, Switzerland, Italy, Spain, Russia, Turkey, Netherlands and Rest of
Europe) – Trends and Forecast to 2024
This report consists of below pages:
• No of pages: 175
• No of Figures: 30
• No of Tables: 125
Get Free Sample Report@ http://databridgemarketresearch.com/request-a-sample/?dbmr=europe-topical-drug-delivery-market
The
Europe Topical Drug Delivery Market is segmented on the basis of product type,
distribution channel, end user, and geography.
The
key companies involved in this market are:
·
MedPharm
·
Janssen Pharmaceuticals, Inc.,(Johnson & Johnson Services
Inc.)
·
Crescita TherapeuticsiNC.
·
Galderma S.A.
·
Biofarmitalia s.r.l
·
Pharmatek Laboratories, Inc.
·
Stiefel Laboratories, Inc.
·
Tapemark
·
Acrux Limited
·
Nitto Denko Corporation
·
Valeant Pharmaceuticals International, Inc.
·
Skinvisible Pharmaceuticals, Inc.
·
Mylan Pharmaceuticals Inc.
·
Hisamitsu Pharmaceutical Co., Inc.
·
Pocono Coated Products LLC
·
TheraSolve NV.
·
Samyang Biopharmaceuticals Corporation
·
Lohmann Therapie-Systeme AG
·
Prosollus Pharmaceuticals
·
Easton Pharmaceuticals Inc.
·
Novosis AG
·
Antares Pharma, Inc.
·
Endo Pharmaceuticals Inc.
·
Transdermal Technologies, Inc.
·
Sheffield Pharmaceuticals, Inc.
·
Solvay
·
3M Drug Delivery Systems.
For
More Details In-Depth Enquiry @ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=europe-topical-drug-delivery-market
Report Segmentation:
On the basis of product type, the Europe
Topical Drug Delivery Market is segmented into transdermal drug delivery
devices and topical drug delivery formulations. Topical drug delivery
formulations are further segmented based on form into solid, semi-solid, and
liquid. The semi solid segment is further classified into ointments, creams,
lotions, gels, and pastes. The solid drugs segment is further segmented into
powders and suppositors. The liquid drugs segment is further classified into
solutions and suspensions.
The
transdermal drug delivery devices
market segment is further segmented into patches and gels.
On the basis of end users, the Europe Topical Drug Delivery Market is segmented into hospitals, home
healthcare, clinics, diagnostic centers, and others.
Based on country, the Europe Topical Drug Delivery
Market is segmented into Germany, France, United Kingdom., Belgium,
Switzerland, Italy, Spain, Russia, Turkey, Netherlands and Rest of Europe. The
Europe topical drug delivery market is highly fragmented with various companies
operating in local regions. The major players have used various strategies such
as new product launches, expansions, agreements, joint ventures, partnerships,
acquisitions, and others to increase their footprints in this market.
View Full Report Visit @ http://databridgemarketresearch.com/reports/europe-topical-drug-delivery-market/
Table of Contents:
1. INTRODUCTION
1.1. OVERVIEW OF THE EUROPE TOPICAL DRUG
DELIVERY MARKET
1.2. MARKET SEGMENTATION & COVERAGE
2. RESEARCH
METHODOLOGY
2.1. KEY TAKEAWAYS
2.2. ARRIVING AT THE EUROPE TOPICAL DRUG
DELIVERY MARKET SIZE
2.4. EUROPE TOPICAL DRUG DELIVERY MARKET:
RESEARCH SNAPSHOT
2.5. ASSUMPTIONS
3. MARKET
LANDSCAPE SUMMARY
4. PREMIUM
INSIGHTS
4.1. OVERVIEW
4.2. EUROPE TOPICAL DRUG DELIVERY
MARKET: KEY PRIMARY INSIGHTS
4.3. MARKET OVERVIEW
4.4. KEY MARKET TRENDS AND UPCOMING
TECHNOLOGIES
5. EXECUTIVE
SUMMARY
6. TOPICAL DRUG
DELIVERY MARKET, BY PRODUCT TYPE
6.1. OVERVIEW
6.2. TOPICAL DRUG DELIVERY, BY PRODUCT
TYPE
7. TOPICAL DRUG
DELIVERY MARKET, BY END-USER
7.1. OVERVIEW
7.2. HOSPITALS
7.3. HOME HEALTHCARE
7.4. CLINICS
7.5. DIAGNOSTIC CENTERS
7.6. OTHERS
8. TOPICAL DRUG
DELIVERY MARKET, BY DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. HOSPITAL PHARMACIES
8.3. PHARMACY STORES
8.4. DIRECT TENDERS
8.5. ONLINE PHARMACY
9. TOPICAL DRUG
DELIVERY MARKET, BY GEOGRAPHY
9.1. COUNTRYWISE DRUG DELIVERY DEVICES
MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY
COUNTRY)
9.2. KEY PRIMARY
INSIGHTS: BY MAJOR COUNTRIES
10. TOPICAL DRUG
DELIVERY MARKET: COMPETITIVE LANDSCAPE
10.1. EUROPE TOPICAL DRUG DELIVERY
MARKET: COMPANY SHARE ANALYSIS
10.2. U.S. TOPICAL DRUG DELIVERY
MARKET: COMPANY SHARE ANALYSIS
10.4. APAC TOPICAL DRUG DELIVERY
MARKET: COMPANY SHARE ANALYSIS
10.5. SOUTH AMERICA TOPICAL DRUG
DELIVERY MARKET: COMPANY SHARE ANALYSIS
10.6. MIDDLE EAST AND AFRICA
TOPICAL DRUG DELIVERY MARKET: COMPANY SHARE ANALYSIS
10.7. MERGERS & ACQUISITIONS
10.8. NEW PRODUCT DEVELOPMENT &
APPROVALS
10.10. EXPANSIONS
10.10. REGULATORY CHANGES
10.11. PARTNERSHIP AND OTHER
STRATEGIC DEVELOPMENTS
11. TOPICAL DRUG
DELIVERY MARKET, COMPANY PROFILES
11.1. JANSSEN PHARMACEUTICALS, INC.
(A J&J COMPANY)
11.1.1. COMPANY OVERVIEW
11.1.2. SWOT ANALYSIS
11.1.3. REVENUE ANALYSIS
11.1.4. PRODUCT PORTFOLIO
11.1.5. RECENT DEVELOPEMENTS
11.1.5. DATA BRIDGE
ANALYSIS
11.2. CRESCITA THERAPEUTICS
11.2.1. COMPANY OVERVIEW
11.2.2. SWOT ANALYSIS
11.2.3. REVENUE ANALYSIS
11.2.4. PRODUCT PORTFOLIO
11.2.5. RECENT
DEVELOPEMENTS
11.2.5. DATA BRIDGE ANALYSIS
11.3. GALDERMA S.A.
11.3.1. COMPANY OVERVIEW
11.3.2. SWOT ANALYSIS
11.3.3. REVENUE ANALYSIS
11.3.4. PRODUCT PORTFOLIO
11.3.5. RECENT DEVELOPEMENTS
11.3.6. DATA BRIDGE ANALYSIS
11.4. BIOFARMITALIA S.R.L
11.4.1. COMPANY OVERVIEW
11.4.2. SWOT ANALYSIS
11.4.3. REVENUE ANALYSIS
11.4.4. PRODUCT PORTFOLIO
11.4.5. RECENT DEVELOPEMENTS
11.4.5. DATA BRIDGE ANALYSIS
11.5. PHARMATEK LABORATORIES, INC.
11.5.1. COMPANY OVERVIEW
11.5.2. SWOT ANALYSIS
11.5.3. REVENUE ANALYSIS
11.5.4. PRODUCT PORTFOLIO
11.5.5. RECENT
DEVELOPEMENTS
11.5.5. DATA BRIDGE ANALYSIS
11.6. STIEFEL LABORATORIES, INC.
11.6.1. COMPANY OVERVIEW
11.6.2. SWOT ANALYSIS
11.6.3. REVENUE ANALYSIS
11.6.4. PRODUCT PORTFOLIO
11.6.5. RECENT DEVELOPEMENTS
11.6.5. DATA BRIDGE ANALYSIS
11.7. TAPEMARK
11.7.1. COMPANY OVERVIEW
11.7.2. SWOT ANALYSIS
11.7.3. REVENUE ANALYSIS
11.7.4. PRODUCT PORTFOLIO
11.7.5. RECENT DEVELOPEMENTS
11.7.6. DATA BRIDGE ANALYSIS
11.8. NITTO DENKO CORPORATION
11.8.1. COMPANY OVERVIEW
11.8.2. SWOT ANALYSIS
11.8.3. REVENUE ANALYSIS
11.8.4. PRODUCT PORTFOLIO
11.8.5. RECENT DEVELOPEMENTS
11.8.6. DATA BRIDGE ANALYSIS
11.9. VALEANT PHARMACEUTICALS
INTERNATIONAL, INC.
11.9.1. COMPANY OVERVIEW
11.9.2. SWOT ANALYSIS
11.9.3. REVENUE ANALYSIS
11.9.4. PRODUCT PORTFOLIO
11.9.5. RECENT DEVELOPEMENTS
11.9.6. DATA BRIDGE ANALYSIS
11.9. MYLAN PHARMACEUTICALS INC.
11.9.1. COMPANY OVERVIEW
11.9.2. SWOT ANALYSIS
11.9.3. REVENUE ANALYSIS
11.9.4. PRODUCT PORTFOLIO
11.9.5. RECENT DEVELOPEMENTS
11.9.6. DATA BRIDGE ANALYSIS
11.9. HISAMITSU PHARMACEUTICAL CO.,
INC.
11.9.1. COMPANY OVERVIEW
11.9.2. SWOT ANALYSIS
11.9.3. REVENUE ANALYSIS
11.9.4. PRODUCT PORTFOLIO
11.9.5. RECENT DEVELOPEMENTS
11.9.5. DATA BRIDGE ANALYSIS
11.10. THERASOLVE NV.
11.10.1. COMPANY OVERVIEW
11.10.2. SWOT ANALYSIS
11.10.3. REVENUE ANALYSIS
11.10.4. PRODUCT PORTFOLIO
11.10.5. RECENT DEVELOPEMENTS
11.10.6. DATA BRIDGE ANALYSIS
11.11. SAMYANG BIOPHARMACEUTICALS
CORPORATION
11.11.1. COMPANY OVERVIEW
11.11.2. SWOT ANALYSIS
11.11.3. REVENUE ANALYSIS
11.11.4. PRODUCT PORTFOLIO
11.11.5. RECENT DEVELOPEMENTS
11.11.6. DATA BRIDGE ANALYSIS
11.12. LOHMANN THERAPIE-SYSTEME AG
11.12.1. COMPANY OVERVIEW
11.12.2. SWOT ANALYSIS
11.12.3. REVENUE ANALYSIS
11.12.4. PRODUCT PORTFOLIO
11.12.5. RECENT DEVELOPEMENTS
11.12.6. DATA BRIDGE ANALYSIS
11.13. PROSOLLUS PHARMACEUTICALS
11.13.1. COMPANY OVERVIEW
11.13.2. SWOT ANALYSIS
11.13.3. REVENUE ANALYSIS
11.13.4. PRODUCT PORTFOLIO
11.13.5. RECENT DEVELOPEMENTS
11.13.6. DATA BRIDGE ANALYSIS
11.14. EASTON PHARMACEUTICALS INC.
11.14.1. COMPANY OVERVIEW
11.14.2. SWOT ANALYSIS
11.14.3. REVENUE ANALYSIS
11.14.4. PRODUCT PORTFOLIO
11.14.5. RECENT DEVELOPEMENTS
11.14.6. DATA BRIDGE ANALYSIS
11.15. ANTARES PHARMA, INC.
11.15.1. COMPANY OVERVIEW
11.15.2. SWOT ANALYSIS
11.15.3. REVENUE ANALYSIS
11.15.4. PRODUCT PORTFOLIO
11.15.5. RECENT DEVELOPEMENTS
11.15.6. DATA BRIDGE ANALYSIS
11.16. ENDO PHARMACEUTICALS INC.
11.16.1. COMPANY OVERVIEW
11.16.2. SWOT ANALYSIS
11.16.3. REVENUE ANALYSIS
11.16.4. PRODUCT PORTFOLIO
11.16.5. RECENT DEVELOPEMENTS
11.16.6. DATA BRIDGE ANALYSIS
11.17. TRANSDERMAL TECHNOLOGIES, INC.
11.17.1. COMPANY OVERVIEW
11.17.2. SWOT ANALYSIS
11.17.3. REVENUE ANALYSIS
11.17.4. PRODUCT PORTFOLIO
11.17.5. RECENT DEVELOPEMENTS
11.17.6. DATA BRIDGE ANALYSIS
11.18. SHEFFIELD PHARMACEUTICALS, INC.
11.18.1. COMPANY OVERVIEW
11.18.2. SWOT ANALYSIS
11.18.3. REVENUE ANALYSIS
11.18.4. PRODUCT PORTFOLIO
11.18.5. RECENT DEVELOPEMENTS
11.18.6. DATA BRIDGE ANALYSIS
11.19. SOLVAY
11.19.1. COMPANY OVERVIEW
11.19.2. SWOT ANALYSIS
11.19.3. REVENUE ANALYSIS
11.19.4. PRODUCT PORTFOLIO
11.19.5. RECENT DEVELOPEMENTS
11.19.6. DATA BRIDGE ANALYSIS
11.20. 3M DRUG DELIVERY SYSTEMS
11.20.1. COMPANY
OVERVIEW
11.20.2. SWOT ANALYSIS
11.20.3. REVENUE ANALYSIS
11.20.4. PRODUCT PORTFOLIO
11.20.5. RECENT DEVELOPEMENTS
11.20.6. DATA BRIDGE
ANALYSIS
Related Report
Global
Topical Drug Delivery Market – Trends and Forecast to 2024
Global Topical Drug
Delivery Market, By Product Type {Topical (Solid, Liquid, Semi-Solid),
Transdermal (Patches, Gels)}; End-User (Hospitals, Clinics, Home Healthcare,
Diagnostic Centers, Others); Distribution Channel (Direct Tenders, Retail);
Geography (North America, Europe, Asia-Pacific, Latin America, Rest of the
World) – Trends and Forecast to 2024
About Data Bridge Market
Research:
Data Bridge
Market Research set forth itself as an unconventional and neoteric
Market research and consulting firm with unparalleled level of resilience and
integrated approaches. We are determined to unearth the best market
opportunities and foster efficient information for your business to thrive in
the market. Data Bridge endeavors to provide appropriate solutions to the
complex business challenges and initiates an effortless decision-making
process.
Contact:
Vishal
Dixit
Data
Bridge Market Research
Tel:
+1-888-387-2818
Follow us on LinkedIn: https://www.linkedin.com/company/data-bridge-market-research